Marion Bertrand

MSc
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)

Presentation(s):

• OP-22A - Risk of Myocardial Infarction, Stroke or Death in New Users of Intravitreal Aflibercept versus New Users of Intravitreal Ranibizumab: A Nationwide Cohort Study

  Monday, August 23, 2021
  1:45 PM – 3:30 PM US Eastern Time